Skip to main content
. 2005 May 3;92(10):1869–1876. doi: 10.1038/sj.bjc.6602551

Figure 3.

Figure 3

Zoledronic acid significantly improved Brief Pain Inventory (BPI) pain scores. Brief Pain Inventory was assessed at baseline, at the end of each cycle, and at final visit. Graph depicts mean change from baseline BPI scores reported during the hospital crossover phase, community crossover phase, and overall (score reported at final visit after nine infusions). *P<0.05; †P<0.005 compared with baseline values.